Aptissen is a company specialized in the research, development and commercialization of biopolymer-based medical devices. Aptissen SA stands for Advanced Polymer for TISSue ENgineering, which clearly gives a hint about the company’s skills. Aptissen’s founders have developed for the past 25 years the best quality injectable products to meet patient’s needs. Today we are active in the fields of Ophthalmology through surgical solutions for cataract and glaucoma, and of Orthopaedics, through innovative treatments for osteoarthritis.
OUR VISION
Aptissen considers that the future of treatments for the synovial joints requires effective treatments administered in a single session, providing an improvement in mobility and a fast pain relief, as well as the regeneration of cartilage.
OUR MISSION
We place the patient benefit at the center of our mission to develop innovative injectable solutions based on hyaluronic acid that can be combined with other molecules. We plan to bring a clinically proven global approach, including oral or topical forms.
OUR PORTFOLIO
In Orthopaedics: Aptissen launched Synolis VA, the first Visco-Antalgic indicated for osteoarthritic synovial joints treatment. In Ophthalmology, Aptissen has developed HealaFlow the only injectable filtering spacer for Glaucoma surgery.
ORTHOPAEDICS
Synolis VA intra-articular injection for osteoarthritis, the first Visco-Antalgic on the market, is a unique combination of Hyaluronic Acid and high concentration of Sorbitol.
OPHTHALMOLOGY
HealaFlow is an injectable filtering spacer used to optimize glaucoma filtration.
APTISSEN TEAM
The Aptissen team, originating from Anteis, owns knowledge and experience of both products and markets.
